Teleradiology provider Medica Group has agreed to integrate Axon Diagnostics into its business, in a transaction expected to strengthen its remote diagnostic reporting capabilities across the UK National Health Service (NHS) and the private healthcare sector.
The organisations confirmed that the merger, while financial terms remain undisclosed, will establish what they describe as the largest clinical reporting network in the UK. The combined service is set to span major diagnostic subspecialties and expand capacity to manage both routine and urgent cases.
Medica currently delivers remote teleradiology reporting services to radiology departments across 55% of NHS Trusts. Its clinical focus areas include stroke imaging, cardiac, PET CT, and nuclear medicine, supporting hospitals with off-site specialist expertise.
Axon Diagnostics operates in digital pathology, working with NHS and private healthcare providers to manage caseloads and enable remote reporting workflows. Its cloud-based teleradiology and telepathology platform underpins these services, allowing clinicians to access and report cases remotely.
Through the integration of Axon’s platform and artificial intelligence (AI)-based workflow tools alongside clinical desktop technology from Axon’s sister company, MITIS Medica stated that the enlarged organisation will introduce more streamlined workflows. The aim, it said, is to enhance efficiency and cost effectiveness for clients, in line with the NHS’s long term priorities.
The announcement comes against the backdrop of the UK government’s 10-year plan for the NHS, unveiled in July 2025. In that plan, the UK’s Labour government highlighted the acceleration of AI deployment in hospitals to support clinical reporting in radiology and pathology. The strategy also emphasised remote monitoring to enable virtual care for patients at home.
Medica CEO Andrew Cannon commented: “Bringing Axon into Medica strengthens our position as the UK’s leading diagnostics provider. Clients will continue to receive the excellent service they rely on, now supported by greater capacity and advanced reporting technology.”
To finalise the merger, both companies said they are implementing a phased integration plan designed to bring together their systems, teams, and best practice protocols in a “structured and transparent” manner.
Axon CEO Rahul Mehta commented: “This merger combines our technology and agile approach with Medica’s scale and clinical excellence, meaning more patients will benefit from faster and smarter reporting.”
The transaction also unfolds amid workforce pressures in UK radiology. According to the Royal College of Radiologists (RCR), the country faces a 30% shortfall in clinical radiologists, a figure projected to increase to 40% by 2028 if no corrective measures are taken. In response to these constraints, teleradiology has increasingly served as a key stopgap solution, helping to ease clinician burnout while addressing rising caseloads.
